Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2003
07/16/2003EP1246809B1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
07/16/2003EP1235579B1 Pharmaceutical compositions comprising trimegestone
07/16/2003EP1224182B1 N-substituted 1-(butyrolactone)-isoquinolines for treating nervous disorders
07/16/2003EP1210353B1 Calcium complex of phosphorus containing ethylenediamine derivatives
07/16/2003EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
07/16/2003EP1175416B1 Heteroaryl diazacycloalkanes, their preparation and use
07/16/2003EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
07/16/2003EP1155000B1 2-aminopyridines containing fused ring substituents
07/16/2003EP1112066B1 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor
07/16/2003EP1109789B1 Triptolide prodrugs having high aqueous solubility
07/16/2003EP1084104B1 Nitric oxide synthase inhibitors
07/16/2003EP1076558B1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
07/16/2003EP1070069B1 Bicyclic hydroxamic acid derivatives
07/16/2003EP1054669B1 Use of thiadiazolo[4,3-a]pyridine derivatives
07/16/2003EP1032266A4 Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis
07/16/2003EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them
07/16/2003EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1
07/16/2003EP0983059B1 Process for making flurbiprofen lozenges
07/16/2003EP0934059B1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
07/16/2003EP0852586B1 Use of a 24 kDa protein for treating and diagnosing an HCV Infektion
07/16/2003EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
07/16/2003EP0814793B1 Prilocaine and hydrofluorocarbon aerosol preparations
07/16/2003EP0814790B1 Administration of ketamine for detoxification
07/16/2003EP0760013B1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin
07/16/2003EP0758328B1 Anti-cancer compounds containing cyclopentaquinazoline ring
07/16/2003EP0550550B1 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
07/16/2003CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof
07/16/2003CN1430624A Novel solid body forms of mesoprogestin 11-beta-[4E-(hydroxyimino methyl)-phenyl]-17-alpha-methoxy methyl-17 beta-methoxy-estra-4,9-dien-3-one
07/16/2003CN1430621A New process for preparation of vinyl-pyrrolidinone cephalosporine derivatives
07/16/2003CN1430620A Macrolides compound
07/16/2003CN1430618A Thiazine oxazolidinone
07/16/2003CN1430617A Process for producing carbostyril derivative
07/16/2003CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430612A Hete rocyclic derivatives
07/16/2003CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha
07/16/2003CN1430602A Ary-and heteroaryl sulfonates compounds
07/16/2003CN1430600A 7-and 9-carbamate, urea, thiourea, thiocarbamate and heteroaryl-amino substituted tetracycline compounds
07/16/2003CN1430599A Phenylglycine derivatives
07/16/2003CN1430597A Novel MMP-2/MMP-9 inhibitors
07/16/2003CN1430596A New gamma selective retinoids
07/16/2003CN1430521A Solid dispersion system of Pranlukast with improved dissolution, and the preparing method thereof
07/16/2003CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof
07/16/2003CN1430517A Pepsin inhabition by alginates
07/16/2003CN1430515A Divided dose therapies with vascular damaging activity
07/16/2003CN1430514A Use of galantamine for treatment of neuropsychiatric behaviour associated with alzheimer's disease
07/16/2003CN1430513A Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia
07/16/2003CN1430512A Modulation of bone formation
07/16/2003CN1430511A Method of improving survival of patients
07/16/2003CN1430510A Novel formulations of alpha 2,4-disulforphenyl-N-tert-butylnitrone
07/16/2003CN1430509A Method for controlling septemia shock
07/16/2003CN1430508A Novel composition
07/16/2003CN1430505A Microspheres for active embolization
07/16/2003CN1430503A O/W emulsion
07/16/2003CN1430502A Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds
07/16/2003CN1430501A Preparation of injectable suspensions having improved injectabity
07/16/2003CN1430474A Tryptophan source from plants and uses therefor
07/16/2003CN1430470A Active substance combinations with insecticidal and acaricidal properties
07/16/2003CN1429905A Recombination adenopathy adjoint virus carrier capable of controlling digene expression for treating parkinsonism
07/16/2003CN1429830A Water-soluble safflower extract and its oral preparation for treating and preventing angiocardiopathy andcerebrova scular disease
07/16/2003CN1429826A Preparation method and use of sodium Penciclovir sodium hydrate
07/16/2003CN1429825A Guanine compound, its preparation method and application
07/16/2003CN1429824A New compound separated from safflower, its preparation method and medical use
07/16/2003CN1429815A Compound N-total trans dimension methanamide derivative and its preparation method and application
07/16/2003CN1429807A Synthesis of antitumour medicine bexarotene
07/16/2003CN1429805A Method for synthesizing conjugated linoleic acid using mixed solvent
07/16/2003CN1429623A Method for treating endothelium wond
07/16/2003CN1429618A Erigeron breviscapus oral caving fast disintegration tablet and its preparation method
07/16/2003CN1429616A New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method
07/16/2003CN1429611A Greater celandine extract and its preparation method and application
07/16/2003CN1429605A Drug composition for preventing and treating prospermia and/or sexual excitation hypersensitivity
07/16/2003CN1429560A Application of chitose in composition for eye use
07/16/2003CN1429559A Anti-adhesion isolator
07/16/2003CN1429558A Mannosan peptide injection and its preparation and use method
07/16/2003CN1429557A Chinese medicinal preparation containing lilyturf root polysaccharide and its preparation method
07/16/2003CN1429556A Muscle strong agent and anti-inflammatory agent
07/16/2003CN1429555A Adfuwei ester soft capsule and its preparation method
07/16/2003CN1429554A Compound beri-beri ointment
07/16/2003CN1429553A Use of centella total glycoside in manufacture of medicine
07/16/2003CN1429552A Medical use of 11,11'-dideoxy wotixilin
07/16/2003CN1429551A Treating diabetes by thiazolidine-diketo and dimethylbiguanide
07/16/2003CN1429550A Matrine enteric coatel tablet and its preparation method
07/16/2003CN1429549A Matrine capsule and its preparation method
07/16/2003CN1429548A Medicine for treating disease related to low cyclo GMP level
07/16/2003CN1429547A Coronary artery skeleton medicinal coating for preventing restenosis of blood vessel
07/16/2003CN1429546A Application of 4-methyl cyclopentadecanone in manufacture of medicine
07/16/2003CN1429544A Natural carotene soft capsule and its production method
07/16/2003CN1114690C Papilloma pseudovirus and process for preparing same
07/16/2003CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same
07/16/2003CN1114607C Carbostyril carboxylic acid derivatives
07/16/2003CN1114605C Novel camptothecine derivatives
07/16/2003CN1114604C Bicyclic aryl carboxamides and their therapeutic use
07/16/2003CN1114598C Aromatic compounds and pharmaceutical compositions containing them
07/16/2003CN1114597C Quinoline derivs
07/16/2003CN1114596C Biphenyl derivatives
07/16/2003CN1114594C D4 receptor selectivity piperazine derivatives
07/16/2003CN1114592C Crystalline forms of osanetant
1 ... 5407 5408 5409 5410 5411 5412 5413 5414 5415 5416 5417 5418 5419 5420 5421 5422 5423 5424 5425 5426 5427 ... 7860